Literature DB >> 28340358

Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages.

David Fong1, Pascal Grégoire-Gélinas2, Alexandre P Cheng2, Tal Mezheritsky2, Marc Lavertu2, Sachiko Sato3, Caroline D Hoemann4.   

Abstract

Chitosan is a family of glucosamine and N-acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60-98%), molecular weight (1 to >100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5-50 μg/mL, or activated the inflammasome to release IL-1β and PGE2 at 50-150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT-2 activation that could be suppressed by PGE2. Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chitin/chitosan; Immunomodulation; Inflammasome; Macrophage; Type 1 interferon

Mesh:

Substances:

Year:  2017        PMID: 28340358     DOI: 10.1016/j.biomaterials.2017.03.022

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

1.  The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome.

Authors:  Jessalyn J Baljon; Aamina Dandy; Lihong Wang-Bishop; Mohamed Wehbe; Max E Jacobson; John T Wilson
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

2.  Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage.

Authors:  David Fong; Caroline D Hoemann
Journal:  Future Sci OA       Date:  2017-09-14

3.  Immunomodulation of the NLRP3 Inflammasome through Structure-Based Activator Design and Functional Regulation via Lysosomal Rupture.

Authors:  Saikat Manna; William J Howitz; Nathan J Oldenhuis; Alexander C Eldredge; Jingjing Shen; Fnu Naorem Nihesh; Melissa B Lodoen; Zhibin Guan; Aaron P Esser-Kahn
Journal:  ACS Cent Sci       Date:  2018-07-02       Impact factor: 14.553

4.  A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response.

Authors:  Charles S Fermaintt; Kanae Sano; Zhida Liu; Nozomi Ishii; Junichi Seino; Nicole Dobbs; Tadashi Suzuki; Yang-Xin Fu; Mark A Lehrman; Ichiro Matsuo; Nan Yan
Journal:  Nat Commun       Date:  2019-05-30       Impact factor: 14.919

5.  A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect via Mitochondrial DNA Stress-Dependent Type I Interferon Production.

Authors:  Yu-Min Choi; Hong Kim; Seoung-Ae Lee; So-Young Lee; Bum-Joon Kim
Journal:  Front Immunol       Date:  2020-05-21       Impact factor: 7.561

6.  Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana In Vitro.

Authors:  Alaa Riezk; John G Raynes; Vanessa Yardley; Sudaxshina Murdan; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

7.  Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size.

Authors:  Caroline D Hoemann; Javier Rodríguez González; Jessica Guzmán-Morales; Gaoping Chen; Ebrahim Jalali Dil; Basil D Favis
Journal:  Bioact Mater       Date:  2021-09-16

Review 8.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

Review 9.  Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine.

Authors:  Bolat Sultankulov; Dmitriy Berillo; Karina Sultankulova; Tursonjan Tokay; Arman Saparov
Journal:  Biomolecules       Date:  2019-09-10

10.  Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine.

Authors:  Gao-Na Shi; Min Hu; Chengjuan Chen; Junmin Fu; Shuai Shao; Yu Zhou; Lei Wu; Tiantai Zhang
Journal:  Ther Adv Med Oncol       Date:  2021-01-21       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.